AAAAAA

   
Results: 1-8 |
Results: 8
SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety
Authors: Wood, MD Reavill, C Trail, B Wilson, A Stean, T Kennett, GA Lightowler, S Blackburn, TP Thomas, D Gager, TL Riley, G Holland, V Bromidge, SM Forbes, IT Middlemiss, DN
Citation: Md. Wood et al., SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety, NEUROPHARM, 41(2), 2001, pp. 186-199
1-[2-[(heteroaryloxy)heteroaryl]carbamoyl]indolines: Novel and selective 5-HT2C receptor inverse agonists with potential as antidepressant/anxiolyticagents
Authors: Bromidge, SM Dabbs, S Davies, S Duckworth, DM Forbes, IT Jones, GE Jones, J King, FD Saunders, DV Blackburn, TP Holland, V Kennett, GA Lightowler, S Middlemiss, DN Riley, GJ Trail, B Wood, MD
Citation: Sm. Bromidge et al., 1-[2-[(heteroaryloxy)heteroaryl]carbamoyl]indolines: Novel and selective 5-HT2C receptor inverse agonists with potential as antidepressant/anxiolyticagents, BIOORG MED, 10(16), 2000, pp. 1863-1866
1-[2-[(heteroarylmethoxy)aryl]carbamoyl]indolines are selective and orallyactive 5-HT2C receptor inverse agonists
Authors: Bromidge, SM Davies, S Duckworth, DM Forbes, IT Jones, GE Jones, J King, FD Blackburn, TP Holland, V Kennett, GA Lightowler, S Middlemiss, DN Riley, GJ Trail, B Wood, MD
Citation: Sm. Bromidge et al., 1-[2-[(heteroarylmethoxy)aryl]carbamoyl]indolines are selective and orallyactive 5-HT2C receptor inverse agonists, BIOORG MED, 10(16), 2000, pp. 1867-1870
5-HT6 receptors as emerging targets for drug discovery
Authors: Branchek, TA Blackburn, TP
Citation: Ta. Branchek et Tp. Blackburn, 5-HT6 receptors as emerging targets for drug discovery, ANN R PHARM, 40, 2000, pp. 319-334
Immunohistochemical localisation of the 5-HT2C receptor protein in the ratCNS
Authors: Clemett, DA Punhani, T Duxon, MS Blackburn, TP Fone, KCF
Citation: Da. Clemett et al., Immunohistochemical localisation of the 5-HT2C receptor protein in the ratCNS, NEUROPHARM, 39(1), 2000, pp. 123-132
Biarylcarbamoylindolines are novel and selective 5-HT2C receptor inverse agonists: Identification of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a potential antidepressant/anxiolytic agent
Authors: Bromidge, SM Dabbs, S Davies, DT Davies, S Duckworth, DM Forbes, IT Gaster, LM Ham, P Jones, GE King, FD Mulholland, KR Saunders, DV Wyman, PA Blaney, FE Clarke, SE Blackburn, TP Holland, V Kennett, GA Lightowler, S Middlemiss, DN Trail, B Riley, GJ Wood, MD
Citation: Sm. Bromidge et al., Biarylcarbamoylindolines are novel and selective 5-HT2C receptor inverse agonists: Identification of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a potential antidepressant/anxiolytic agent, J MED CHEM, 43(6), 2000, pp. 1123-1134
Model studies on a synthetically facile series of N-substituted phenyl-N '-pyridin-3-yl ureas leading to 1-(3-pyridylcarbamoyl) indolines that are potent and selective 5-HT2C/2B receptor antagonists
Authors: Bromidge, SM Dabbs, S Davies, DT Davies, S Duckworth, DM Forbes, IT Gadre, A Ham, P Jones, GE King, FD Saunders, DV Thewlis, KM Vyas, D Blackburn, TP Holland, V Kennett, GA Riley, GJ Wood, MD
Citation: Sm. Bromidge et al., Model studies on a synthetically facile series of N-substituted phenyl-N '-pyridin-3-yl ureas leading to 1-(3-pyridylcarbamoyl) indolines that are potent and selective 5-HT2C/2B receptor antagonists, BIO MED CH, 7(12), 1999, pp. 2767-2773
Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist
Authors: Reavill, C Kettle, A Holland, V Riley, G Blackburn, TP
Citation: C. Reavill et al., Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist, BR J PHARM, 126(3), 1999, pp. 572-574
Risultati: 1-8 |